DECKERS OUTDOOR CORP quarterly report, Q1 FY2005

Business Context and Reporting Period

Company: Deckers Outdoor Corp.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2005
Business Overview: Deckers is a leading producer and brand manager of innovative footwear, operating three primary brands: Teva (sport sandals/outdoor), UGG (luxury sheepskin), and Simple (casual/athletic). The company sells through wholesale channels and its own Internet/catalog retailing business. The business is seasonal, with Teva sales peaking in Q1/Q2 and UGG sales peaking in Q3/Q4.

Key Financial Metrics

Metric Q1 2005 Q1 2004
Net Sales $64,263,000 $44,272,000
Gross Profit $29,567,000 $20,406,000
Gross Margin 46.0% 46.1%
Income from Operations $14,399,000 $9,628,000
Operating Margin 22.4% 21.7%
Net Income $8,887,000 $5,382,000
Diluted EPS $0.69 $0.49
Cash and Equivalents (End of Period) $17,634,000 $10,848,000
Working Capital $79,201,000 $69,854,000 (Dec 31, 2004)
Long-Term Debt $0 $0

Liquidity: The company maintains a $20,000,000 revolving credit facility with Comerica Bank. As of March 31, 2005, there were no outstanding borrowings, letters of credit, or foreign currency reserves, leaving full availability of $20,000,000.

Material Changes vs. Prior Period

  • Revenue Growth: Net sales increased 45.2% year-over-year, driven by a 27.4% increase in unit volume and a 14.1% increase in weighted average wholesale selling price.
  • UGG Brand Surge: UGG wholesale sales skyrocketed 608.5% to $18.75 million, fueled by the introduction of a Spring product line (absent in 2004) and the ability to fulfill carryover orders from the previous season.
  • Simple Turnaround: Simple wholesale sales grew 40.1%, turning an operating loss of $163,000 in Q1 2004 into a profit of $203,000 in Q1 2005.
  • Inventory Build: Inventories increased 50.2% to $45.4 million, primarily due to a $13.0 million increase in UGG inventory to meet anticipated demand for the Fall/Winter season.
  • Cash Flow: Operating cash flow turned negative at $(7.96) million compared to positive $7.33 million in the prior year, largely due to significant cash outflows for inventory purchases and paying down accounts payable.

Guidance, Outlook, and Risks

Management Commentary: Management expects the trend of higher sales in the second half of the year to continue, driven by UGG growth and the introduction of a Fall Teva line. The company is expanding distribution channels for Teva and Simple while maintaining selective distribution for UGG to protect brand equity.

Key Risks and Contingencies:

  • Supply Chain Constraints: UGG production is heavily dependent on top-quality sheepskin, which is in limited supply. Shortages or price increases could impact margins and ability to meet demand.
  • Seasonality: Results are highly seasonal; Q1/Q2 are strong for Teva, while Q3/Q4 are critical for UGG.
  • Intellectual Property: The company faces ongoing litigation and enforcement actions regarding counterfeit products and unauthorized trademark use globally.
  • Accounting Changes: The company must adopt SFAS No. 123R (Share-Based Payment) effective January 1, 2006, which will require fair value recognition of stock-based compensation.

Investor Verification Checklist

  • Inventory Valuation: Verify the adequacy of inventory reserves given the 50% increase in stock levels and the risk of obsolescence if UGG demand slows.
  • Sheepskin Supply: Monitor reports on sheepskin availability and pricing, as this is a critical bottleneck for the high-margin UGG brand.
  • Bad Debt Exposure: Review the allowance for doubtful accounts, which increased due to non-payment by a terminated U.K. distributor.
  • Seasonal Sales Mix: Confirm that Q2 sales align with the expected Teva seasonality and that Q3/Q4 UGG sales materialize to justify the current inventory build.
  • Stock Compensation Impact: Assess the potential impact of the upcoming SFAS 123R adoption on future net income and EPS.